Women who use combined oral contraceptives containing estrogen and progestogen have an associated two- to eight-fold increased risk of venous thromboembolism. Over the years, in an attempt to reduce ...

Reassuringly, a history of oral contraceptive use had no deleterious effects on cardiovascular disease (CVD) and survival over long-term follow-up, a U.K. Biobank study showed. In a comparison between ...

The van Hylckama Vlieg study was a population case-control study of premenopausal women aged 18-50 years, based on data from the Multiple Environment and Genetic Assessment of Risk Factors for Venous ...